Merck KGaA (NYSE:MRK) R&D Update Conference Call June 14, 2019 8:30 AM ET
Company Participants
Constantin Fest – Head-Investor Relations
Luciano Rossetti – Global Head-Research and Development
Rehan Verjee – President-EMD Serono and Global Head-Innovative Medicine Franchises
Joern-Peter Halle – Head-External Innovation and Head-TIP Immuno Oncology
Conference Call Participants
Wimal Kapadia – Bernstein
Joe Lockey – Morgan Stanley
Sachin Jain – Bank of America
Michael Leuchten – UBS
Richard Vosser – JPMorgan
Luisa Hector – Exane
Emily Field – Barclays
Simon Baker – Redburn
Falko Friedrichs – Deutsche Bank
Constantin Fest
Very warm welcome. Thank you, Cynthia. Warm welcome to this R&D Update Call 2019. My name is Constantin Fest, Head of Investor Relations. And I’m delighted to have with me here today Luciano Rossetti; as well as Rehan Verjee. Luciano our Global Head of Research and Development; Rehan, President of EMD Serono and Global Head of the Innovative Medicine Franchises, and also I’m very happy that supporting for the Q&A, we also have Joern-Peter Halle, Head of External Innovation and Head of TIP Immuno Oncology here with us. And in the next few minutes, we’d like to run you through the key slides of this presentation following that, take all of your questions.
Having said that, happy to hand over to Luciano, so start this call.

